Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $2,079.00 |
|---|---|
| Enterprise Value | $-86,195.00 |
| Earnings per Share | $-0.97 |
| Beta | 1.71 |
| Outstanding Shares | 616,094 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.16 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
AIFarm, Ltd., a development-stage enterprise, specializes in developing and implementing a distinctive growing system. This system involves the global design and construction of tailor-made biodomes, which are utilized by a wide array of...